Phase II Study of SOM230 in Patients With Recurrent or Progressive Meningioma
Status:
Terminated
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
This is a single-arm, phase II trial of SOM230 in patients with documented recurrent or
progressive intracranial meningioma who have failed conventional therapy and are not
candidates for complete surgical resection of their tumors and/or radiation at the time of
study entry.
At the time of the final analysis, all patients who are receiving treatment with SOM230 will
complete the core phase of the study and will continue on the extension phase. During this
time, additional data on response duration, PFS, and safety will be collected.